News
The IMPACT trial reinforces the need to check for antiphospholipid syndrome in women after they experience stillbirth and is ...
Baebies receives US FDA breakthrough device designation for first point-of-care heparin monitoring test: Durham, North Carolina Friday, April 25, 2025, 14:00 Hrs [IST] Baebies, a ...
Baebies Receives FDA Breakthrough Device Designation for First Point-of-Care Heparin Monitoring Test
Baebies has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Anti-Factor Xa ...
Thousands of miles from a manufacturing plant in China, where the key active ingredient in heparin is sourced, Wanda Crowell ...
Background: The Food and Drug Administration-approved argatroban dose for heparin-induced thrombocytopenia (HIT) is 2 µg/kg/min (0.5 µg/kg/min in hepatic impairment), adjusted to achieve ...
The NHS says taking too high a dose of lercanidipine can make you feel dizzy and sleepy. The alert from the MHRA said on Thursday that it was informed by Italian pharmaceutical firm Recordati that ...
The Central Drugs Standard Control Organisation (CDSCO) has instructed drug regulators across all states and Union Territories to immediately stop the manufacture, sale, and distribution of 35 ...
Life-brand melatonin tablets are being recalled because they have the wrong dosing instructions on the label. The recall, published by Health Canada, did not specify what the incorrect ...
At its meeting on Tuesday, the CDC's Advisory Committee on Immunization Practices (ACIP) considered whether the U.S. should move to single-dose human papillomavirus (HPV) vaccination instead of ...
HEPARIN and synthetic heparinoids have to be administered parenterally to assure clinical efficacy 1. Since oral administration of these drugs would be highly desirable, numerous compounds were ...
Incidental physical activity (IPA) encompasses activities of daily living outside the leisure-time domain. No dose-response study is available to guide IPA-focused interventions and guidelines. We ...
When we do a phase 1 study, you are typically just looking for a dose that's [safe]. Teclistamab is such a powerful tool when you think about how [many of] these patients would die within the next 9 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results